Announcements Trials
Browse Landscape

Status

Recruiting 12Completed 11Active not recruiting 5Not yet recruiting 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Gastrointestinal 3Sarcoma 2Myeloid 2Lymphoid 2Gynecologic 2Tumor-Agnostic 1Thoracic 1Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 1Lung Neoplasms 1Disease 1Death 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Docetaxel 33Radiosurgery 22Radiotherapy 21Sunitinib 20pembrolizumab 17Gemcitabine 16Cisplatin 16Androgen Antagonists 15enzalutamide 13Nivolumab 13Goserelin 12Blood Specimen Collection 12aldesleukin 11Surveys and Questionnaires 11Prednisone 11Leuprolide 11Cyclophosphamide 11Abiraterone Acetate 11Bevacizumab 10bicalutamide 9Multiparametric Magnetic Resonance Imaging 9Carboplatin 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Gonadotropin-Releasing Hormone 8Filgrastim 8Epirubicin 8Chemotherapy, Adjuvant 8Brachytherapy 8toripalimab 7tislelizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interviews as Topic × Genitourinary × Clear all
NCT01389830 2019-07-18

End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer

M.D. Anderson Cancer Center

Unknown
230 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Death, Disease, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡